Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Allied Critical Metals Extends Santa Helena Zone with 6.0m of 1.02% WO3 at Borralha (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro...
diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 07, 2023 9:19am
RE:$PHRM - fyi ..
COOL DA- FOOL. You can pump sh1ts this thing, but this wont matter to rvv, all that matters is the type c, COOL DA-FOOL, that what you have to tell to mfrank, mess up the type c and this thing go
...more
(27)
•••
cool888
X
Post by
cool888
on Feb 07, 2023 9:07am
$PHRM - fyi ..
https://ca.finance.yahoo.com/news/pharmather-submits-fda-meeting-package-125900274.html
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 06, 2023 1:05pm
RE:$RVV - fyi !
COOL DA-FOOL, email rvv mgt and bug them not to mess up the type c, you can post anysh1t you want but it wont be any help unless rvv passed that type c. COOL- DA FOOL!
(27)
•••
cool888
X
Post by
cool888
on Feb 06, 2023 12:38pm
$RVV - fyi !
https://twitter.com/i/spaces/1mrGmkAMVEzxy
(145)
•••
CrazyProphet
X
Post by
CrazyProphet
on Feb 06, 2023 8:33am
Sounds like a solid move !!!
https://financialpost.com/globe-newswire/revive-therapeutics-secures-mdma-supply-from-pharmala-biotech-for-mdma-transdermal-patch-development
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 06, 2023 8:00am
New Press Release - PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle Patch VANCOUVER, British Columbia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that it has signed on to act as exclusive...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 06, 2023 8:00am
New Press Release - Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has...
read article.
(5)
•••
1ottrunner
X
Comment by
1ottrunner
on Feb 06, 2023 7:49am
RE:RE:RE:RE:RE:RE:Merck covid drug linked to new virus mutations, study says
You're seeing this for what it is now guppy? I thought you might come around. 60 days ago I told you all too pull out of this and jump into BTC, up about 40% since.
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 05, 2023 9:49pm
RE:RE:RE:RE:RE:Merck covid drug linked to new virus mutations, study says
you been pumping for what 3 years! COOL DA- FOOL
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 05, 2023 9:47pm
RE:RE:RE:RE:Merck covid drug linked to new virus mutations, study says
its ok to pump if there are results, nothing!
(27)
•••
cool888
X
Comment by
cool888
on Feb 05, 2023 9:16pm
RE:RE:RE:Merck covid drug linked to new virus mutations, study says
DUMP COMMENTS, as usual......... Please Go back and & Stay in the Basement - U DUMP. No More Mamma's milk, I guess !!
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 05, 2023 7:09pm
RE:RE:Merck covid drug linked to new virus mutations, study says
COOL DA-FOOL, the fcking expected milestones that have missed milestones after milestones now has 1H date, fcking sh1t, what f!,
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 05, 2023 6:47pm
RE:Merck covid drug linked to new virus mutations, study says
COOL DA-FOOL, you can post this sh1ts all you want, but if the type c meet is fcked up, fcked up! all the opportunities that the company has from the very beginning is fcked up and wasted! Yeah COOL
...more
(27)
•••
cool888
X
Post by
cool888
on Feb 03, 2023 8:50pm
Merck covid drug linked to new virus mutations, study says
#Bucillamine to the WORLD !! https://www.livemint.com/science/health/merck-covid-drug-linked-to-new-virus-mutations-study-says-11675300603221.html
(7)
•••
90guppy
X
Comment by
90guppy
on Feb 03, 2023 10:14am
RE:RE:RE:$RVV Enters into Research Collaboration Agreement with $PHRM
COOL DA-FOOL the only news that matters is bucillamine related news for RVV, nothing else matters right now! COOL DA-FOOL.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Get into THE next Gold Play at ground level — Ripasso invites investors in at launch